Delivering the latest trends shaping science, biotech, and healthcare — showcasing work that drives revenue, reputation, and investment for compelling brands — and offering an inside look at the award-winning culture behind it all.
Meeting with other members of Confrad, a collaborative of marketing agencies around the world, always brings powerful perspectives on our industry. Get a glimpse of the compelling themes and fresh insights from this year’s annual general meeting in Berlin.
Nutcracker Therapeutics Unveils NMU-Symphony™ for Rapid RNA Production
The rise of personalized RNA therapies, especially in oncology, is shifting the manufacturing landscape toward small-scale, flexible production. Unlike mass-market vaccines – such as the widely known COVID-19 vaccine – these individualized treatments require rapid, low-volume manufacturing. To meet this growing need, Nutcracker Therapeutics recently unveiled its NMU-Symphony™, the next generation of its Nutcracker® Manufacturing Unit, which is optimized for the small-scale development of RNA, specifically personalized cancer therapeutics. The platform is scalable, and has demonstrated a three-week overall turnaround time from RNA sequence design to released nanoparticle formulated drug product. As the field evolves, the ability to quickly and cost-effectively produce personalized treatments is becoming a cornerstone of next-generation medicine. In partnership with HDMZ, this latest milestone from Nutcracker Therapeutics has caught the attention of GEN.
Creative pursuits can help us grow in unexpected ways. Find out how one project manager’s journey learning pottery shaped her approach to leadership, process, and play — at work and at the wheel.
.png?upscale=true&width=1200&upscale=true&name=image%20(43).png)
.png?upscale=true&width=1120&upscale=true&name=image%20(44).png)
.jpg?upscale=true&width=800&upscale=true&name=events%20post%20(5).jpg)
